Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. (Q47246442)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. |
scientific article |
Statements
1 reference
Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. (English)
1 reference
Martin S Tallman
1 reference
Simrit Parmar
1 reference
Lynn M Rundhaugen
1 reference
Larry Boehlke
1 reference
MaryBeth Riley
1 reference
Chadi Nabhan
1 reference
Adekunle Raji
1 reference
John L Frater
1 reference
1 September 2004
1 reference
1 reference
28
1 reference
9
1 reference
909-919
1 reference